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Abstract
Background: An avalanche of next generation sequencing (NGS) studies has generated an unprecedented
amount of genomic structural variation data. These studies have also identified many novel gene fusion
candidates with more detailed resolution than previously achieved. However, in the excitement and necessity of
publishing the observations from this recently developed cutting-edge technology, no community standardization
approach has arisen to organize and represent the data with the essential attributes in an interchangeable
manner. As transcriptome studies have been widely used for gene fusion discoveries, the current non-standard
mode of data representation could potentially impede data accessibility, critical analyses, and further discoveries
in the near future.
Results: Here we propose a prototype, Gene Fusion Markup Language (GFML) as an initiative to provide a standard
format for organizing and representing the significant features of gene fusion data. GFML will offer the advantage
of representing the data in a machine-readable format to enable data exchange, automated analysis interpretation,
and independent verification. As this database-independent exchange initiative evolves it will further facilitate
the formation of related databases, repositories, and analysis tools. The GFML prototype is made available at
http://code.google.com/p/gfml-prototype/.
Conclusion: The Gene Fusion Markup Language (GFML) presented here could facilitate the development of a
standard format for organizing, integrating and representing the significant features of gene fusion data in an
inter-operable and query-able fashion that will enable biologically intuitive access to gene fusion findings and
expedite functional characterization. A similar model is envisaged for other NGS data analyses.
Background
Gene fusions are well-recognized molecular events and
serve as genetic markers and drug targets for several
hematological disorders [1,2]. The discovery of recurrent
ETS-family translocations in prostate cancer [3,4], a
RAF kinase gene fusion in ETS-negative prostate cancer
[5,6], and an ALK kinase fusion in lung cancer [7] fur-
ther advocates the significance of gene fusion events
in the development of epithelial cancers [8,9]. The dis-
covery of gene fusion candidates was infrequent and
challenging because of various technological limitations
inherent in traditional techniques, such as spectral
karyotyping, comparative genomic hybridization (CGH),
representational oligonucleotide microarray analysis (ROMA),
fluorescent in situ hybridization (FISH), and Sanger-
based sequencing [10]. However, the rapid evolution of
non-Sanger-based massively parallel sequencing tech-
nologies has empowered an unprecedented sequencing
speed, enabled an unbiased systematic characteriza-
tion of large-scale genome-wide analysis, and surprised
researchers with numerous gene fusion candidates at
an unmatched resolution [11-13]. As this development
in sequencing technology is still relatively new, no
standard approach has been established for reporting
or documenting a number of the key features asso-
ciated with gene fusion discovery leading to a repetitive
process of manual curation and interpretation of critical
information that can entail scrutinizing the entire
manuscript along with the supplementary information.
To enable researchers to remain current with the infor-
mation flow and make the data more accessible, various
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non-standard community efforts have been established
through other structural variation databases [14-17].
These were primarily developed as independent entities
without much scope for data exchange and integrity.
Moreover, the non-standard mode of reporting the rap-
idly increasing gene fusion discoveries has challenged
their manual processes of curation and data entry when
updating the database. Finally, a number of existing
databases are not suited for documenting gene fusion
features and lack many of the key attributes that are
required for next-generation sequencing (NGS) analyses.
In the near future, as we anticipate a downpour of gene
fusion candidates from various high throughput ana-
lyses, representing the data in an unstructured, autono-
mous format poses a significant risk of misplacing such
valuable information. Similar to other standardization
efforts and procedures such as the Minimum Informa-
tion About a Microarray Experiment (MIAME) that
standardizes and shares microarray data [18], the Prote-
omic Standard Initiative-Molecular Interaction (PSI-MI)
that was established to regulate protein-protein inter-
action representation [19], and the Systems Biology
Markup Language (SBML) that represents biochemical
reaction networks [20], there is an urgent need to create
a standard for recording and reporting gene fusion dis-
coveries. Here, we propose a prototype standardization
initiative we call the Gene Fusion Markup Language
(GFML) to propose a standard format for representing
and documenting gene fusions. In turn, this improved
documentation will enable rapid access and maximize
the usage of gene fusion findings to other researchers in
the community. Hence, these proposed guidelines would
serve as a starting point for stricter standards that will
evolve over time in the field as the standards undergo
regular and thorough vetting by the community [21].
Current literature issues
Researchers have tried to practice and adopt the best
possible methods to present their gene fusion data to
the community. However, no standard list of features or
data structures has been discussed or adopted to repre-
sent this special category of observations in an inter-
operable and query-able fashion. In most cases, authors
tend to describe the gene fusion and its features based
on a fusion detection algorithm used for a particular set
of studies and to represent the information based on
their own experience. The depth of information gener-
ated from an NGS analyses pipeline, mostly filtered out
in the published literature, leads to significant informa-
tion loss between the observed and reported findings
(Figure 1A). Here, we summarize some of the key con-
cerns. 1. Representation Format: In published reports
data is simplified and filtered to include only the disease-
specific or study-related gene fusions are described in an
informal format (e.g., a colorful schematic representa-
tion). Other non-recurrent or biologically unrelated gene
fusions for the given study are merely listed in the
Results or the Discussion of the article as a running text
or are at times represented pictorially as a Circos plot,
histogram, or table (as an image). Besides explaining the
significance of the observations, there is no additional
effort to represent the complete analyses outcome in a
consistent and sharable manner. 2. Splice coordinates:
Apart from the fusion genes considered significant for
the respective study, most of the other gene fusion
candidates are simply listed in a table along with the
number of supporting reads. Unfortunately, the features
that help predict their significance are not described.
In order to assess the true biological significance of
candidate fusion transcripts, the splice coordinates (exon
junction) are essential for the interpretation of the read-
ing frame and domain signature of the fusion product.
For example, the significance of fusion candidates involv-
ing kinase family members or transcription factors can
be easily misinterpreted if there is no functional domain
retained in the open reading frame of the fusion tran-
script. 3. Read evidence: To the best of our knowledge,
there is no published study that reports actual reads
mapped to any candidate gene fusion. Currently, the only
way to access the gene fusion-specific reads is to down-
load the large raw sequence files from public sequence
repositories (only if available and accessible) and perform
the non-trivial task of repeating the complete analyses
that can entail everything from mapping the raw reads to
a fusion discovery pipeline. As there are many fusion
candidates predicted in each study with potential false-
positives, it is vital to retain sequence evidence from the
analysis phase so that the observations can be independ-
ently verified. 4. Terminology: A controlled vocabulary
in presenting the characteristic features of gene fusion
events and their evidence is another potential problem
that needs to be addressed in this discipline. Almost half
a dozen published fusion detection algorithms have been
independently developed. These algorithms are asso-
ciated with a number of discrepancies in naming the
attributes and values describing gene fusion events and
the supporting sequence evidence [22-28].
Existing database issues
There are some common evolving standards towards
representation of generic structural variations [29], but
there is no specialized data exchange standard avail-
able to submit published gene fusion discoveries with
required NGS features to any public repositories or data-
bases. In order to avoid repetitive manual curation and
enhance data accessibility, there have been independent
efforts to curate and document these gene fusion discov-
eries in public databases. The Database of Genomic
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Variants [17,29], the Mitelman Database of Chromo-
some Aberrations and Gene Fusions in Cancer [16], the
Atlas of Genetics and Cytogenetics in Oncology and
Hematology [15], and the Catalogue of Somatic Muta-
tion in Cancer [14] are a few of the most popular and
closely related databases of this kind. Here, we summarize
some of the key concerns with the existing resources.
1. NGS incompatible: NGS features that are specific to
gene fusions are ignored and not captured, with the
current gene fusion entries forcefully accommodated
under generic structural variations. In other words, most
of the existing databases are not yet adapted for NGS ana-
lyses. For example, information pertaining to the sequen-
cing platform, mapping, the fusion detection algorithm,
and the read evidence are omitted, leading to yet another
level of information loss when the information from the
published literature is captured in databases (Figure 1A).
2. Non-interoperable: Most of the existing online data-
bases function independently with different scopes of
operations and report curated data in custom formats not
compatible with one another. In turn, this interrupts the
data exchange and integrity (Figure 1A). 3. Unsynchro-
nized update: Existing databases provides some function
to the community. However, considering the volume of in-
formation generated out of recent NGS analyses and the
current status of non-standard data representation in the
literature, the manual mode of operation involved in cur-
ating and documenting such massive amount of data may
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Figure 1 A) Schematic representation of information and interoperability loss across various stages of communication (from top to
bottom). In the first tier, the trapezoids or cones represent different studies, while the complex shapes (circles + triangles) shown in various
colors represent the parallel observations derived at the analyses level across each study. The input and output at each tier is indicated at the
left and right respectively. The individual shapes (triangles and circles) in the second tier denote the partial and heterogeneous representation
of information carried over to the publication level from the respective analyses of each study. Further changes taking place is reflected in
the shapes in the third tier and represent the reduced and incompatible data across each study curated from the literature. Information and
interoperability loss is indicated by the grey triangle on the left. The double-headed green arrows and red blocks indicate the compatibility
status. B) Schematic representation of the steps (from left to right) in the GFML workflow. 1 & 2: Identification of key components and features
of NGS gene fusion analyses from literature evidence and database curation not readily compatible, 3: Element and attribute standardization,
4 & 5: Implementation of XML Schema. Double-headed green arrows and red blocks indicate the compatibility status.
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significantly hamper the up-to-date status of the database.
4. Incomplete entries: Manual curators primarily focus on
validated gene fusions therefore many other non-validated
candidates listed in the supplementary materials are over-
looked and are represented in only a few of the current
databases. Moreover, the majority of gene fusion candi-
dates predicted from NGS studies are listed in the supple-
mentary materials because of the limited space allowed by
many journals.
Requirement for specialized standard data exchange
format for gene fusions
Various standardization procedures have been adopted
by the community periodically, each designed to handle
various data types generated by different technologies
that is appropriate for the level of information required
for the exchange. For example, BioXSD is a common
generic data exchange format that bridges the gap be-
tween specialized standardization formats [30]; specia-
lized data formats such as MAGE-ML are useful in
describing the minimum information specific to micro-
array experiment [18]; PSI-MI is more applicable for
handling information specific to protein-protein interac-
tions [19]; and Molecular Methods (MolMeth) database
provides the research community with an up-to-date
source of methods and protocols used in molecular biol-
ogy and medicine [31]. Similarly, several sequencing-based
standardization formats have been developed by open-
access and international working bodies such as Genomic
Standards Consortium (MIGS\MIMS\MIENS\MIMARKS\
MIxS) and European Nucleotide Archive (ENA\SRA)
that describe genomic, meta-genomic, and environmen-
tal sequences [32-36]. Previously developed sequencing-
based standardization methods primarily focused on
basic data such as sample information, experimental
setup, machine configuration, sequence traces, reads,
quality scores, assembly, mapping and annotation. How-
ever, standardization procedures describing secondary/
tertiary analyses and their outcomes are limited, espe-
cially in the context of rapidly evolving technological
advances in next generation sequencing. The currently
available Minimum Information about a high-throughput
Nucleotide SeQuencing Experiment (MINSEQE), extends
the MIAME specifications to capture the quantitative
data (expression) from HTS technology, while dbVAR
and GVF are specialized data formats to exchange gen-
omic structural variations [37,38]. Similarly, we envision
a customized standardization procedure to accommodate
the features of gene fusion data arising from the tran-
scriptomic analyses that incorporates valuable attributes
such as description of fusion detection algorithms, 5’ and
3’ fusion transcript annotations, fusion read evidence,
open reading frames, splice junction features, experimen-
tal validation status, functional domain architecture, etc.
currently not provided in a common data exchange for-
mat. Many of the common attributes of gene fusion
schema could potentially be derived from other XML
Schemas (SRA\ENA, PSI-MI, MAGE-ML), such as
“Study”, “Sample”, and “Experiment” but the descriptions
of such elements are also often varied across existing
standardizations and are primarily based on the platform\
technology (sequencing, Co-IP, array-based, etc.,) that are
specifically suited for the generation of information of
primary interest. For example, the element “Experiment”
is fine-tuned to fit sequencing platform details in SRA to
exchange sequence data, in PSI-MI it is structured to
handle protocols which generate protein-protein interac-
tions, and in MAGE-ML it is designed to capture infor-
mation from array based technologies. Therefore in the
proposed GFML prototype, in order to ensure a wide
scope for curation of gene fusion features across diverse
platforms including NGS, FISH, aCGH, qPCR, etc., the
common elements have not been derived from any
of the available individual standards. However, to take
advantage of the existing schema, tools to facilitate
cross-talk and data sharing between various schemas
will be enabled.
Methods
We initiated an investigation to understand the com-
monality and characteristics of the published features
and format in NGS studies specifically involving gene fu-
sion algorithms and related findings [5,6,22-28,39,40].
We identified nine major elements and related attributes
describing the characteristics of gene fusion events and
the sequence evidence. We also investigated the existing
structural variations databases [14-17,39] to understand
the documented features, working model, and current
status of each database. To design and develop a com-
patible and robust data model, we also adopted some
of the relevant features of existing standardization proto-
cols and markup languages [19]. Based on our interpret-
ation of existing sources, we standardized the identified
elements and features and further developed a prototype
(Additional files 1 and 2). The graphical version of
the GFML prototype was made using Altova XMLSpy
version 2011rel3sp1 (http://www.altova.com/). The com-
plete process flow is represented in Figure 1B.
Results
In addition to specifying all required data elements and
features, the model recommends a database-independent
structure and standardizes the data attributes and its
values. The ultimate goal of this model is to provide a
standard framework that enables different types of
complex, biologically meaningful queries in order to
maximize the data usage of the system (Table 1).
“Record_Set” is the root element of the GFML that
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contains one or more records (Figure 2). Each “Record”
is a self-contained unit that allows gene fusion entries
from one to multiple sources. Nine major elements have
been characterized and identified from various transcrip-
tome studies describing gene fusion. A brief introduction
for each element is summarized as follows (detailed tech-
nical comments are available in the XML documenta-
tion): (1) the “Source_List” element allows one or more
source objects, describes the source of the study and nor-
mally refers to the publication or data provider details;
(2) the “Sample_List” allows one or more sample objects
and describes the properties of the biological specimens
associated with the study; (3) the “Experiment_List”
element allows one or more experiments and describes
the experimental parameters associated with the study;
(4) the “Sequence_Platform_List” element allows one or
more sequence platform objects and describes the required
sequencing parameters such as the platform name, descrip-
tion and application type; (5) the “Validation_Platform_
List” elements allow one or more validation platform
objects and describe the validation methods; (6) the “Map-
ping_Algorithm_List” allows one or more mapping algo-
rithm objects and describes the mapping algorithm and its
parameters; (7) the “Fusion_Detection_Algorithm_List”
allows one or more fusion detection algorithm objects and
describes the fusion algorithm and its parameters; (8) the
“Sequence_ Repository_List” elements allow one or more
sequence repository objects and describe the sequence re-
pository details where the raw sequences have been depos-
ited and made accessible; and (9) the “Gene_Fusion_List”
element allows one or more gene fusion objects that de-
scribe the key attributes pertaining to gene fusion ana-
lyses including chromosomal location, gene annotation,
read evidence, ORF status, the splice junction, potential
mechanism, and validation status and is linked to other
elements in the model, including the experiment, sample,
mapping, and the fusion detection algorithm. For accom-
modating the available legacy data, the initial version of
the prototype has been made highly flexible. Only 3 out
of 9 elements (i.e., “source,” “sample,” “gene fusion”),
represented as a thick line in Figure 2, are considered
mandatory, whereas all others are represented as op-
tional elements. As a proof of concept, we further illu-
strated the usefulness of this model with a prostate
cancer-specific gene fusion candidate TMPRSS2-ERG, re-
discovered by next generation sequence analyses [26]
(Additional files 3 and 4). The instance further validated
using the defined XML Schema Definition (Additional
files 1 and 2).
Controlled vocabularies
A central requirement for efficient data exchange is a
common data exchange format, however the presence
of this format is not a guarantee of data compatibility.
Ensuring the standardized use of the data attributes and
its values through documentation and controlled
vocabularies is also essential. Akin to other standardiza-
tion protocols, controlled vocabularies related to gene
fusion attributes and attribute values are subjected to
initial standardization in order to enhance the dynamic
Table 1 Potential biologically relevant queries enabled by GFML
Usage scenario Example
Clinicians Gene identifier Lists fusion candidates that involve ERG
Sample type Lists prostate tissue candidates
Clinical significance Lists leiomyosarcoma candidates
Reference Pubmed ID/author information
Molecular Biologists Protein domain Lists fusion candidates with kinase domain
Break in specific domain Lists fusion that breaks or loses the SH2\SH3 domain
Domain with specific region Lists fusion candidates with 3’ kinase domain
ORF status Lists fusion candidates with potential ORF
Validation status platform Lists fusion candidates with validation status by FISH
Splice pattern Lists non-canonical splice pattern
Fusion product Lists potential fusion proteins/truncated proteins
Fusion mechanism Lists potential inversion
Splice boundary Lists 5’ inter-genic fusion (splice boundary)
Bionform-aticians Sequencing platform Lists candidates from Illumina
Sequence evidence Lists candidates with sequence evidence
Mapping/fusion algorithm Lists candidates detected using Bowtie + Shortfuse algorithm
RPKM/unique count Lists candidates above 50 RPKM
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Root element of the Gene 
Fusion Markup Language
recordSet
attributes
GFML level
GFML version within given 
level
version
minorVersion
Describes one or more fusion 
cadidates as a self-contained 
unit. Multiple entries from 
different files can be 
concatenated into a single 
entrySet.
record
1 α..
Description of the source of 
the entry, usually an 
Organization \ Pubmed
sourceList
Lis t  o f  a l l samples in which the 
gene fusion of this entry 
have been determined
sampleList
Lis t  o f  a l l experiments in which the 
gene fusion of this entry have
been determined
experimentList
List of all sequencing platforms occurring
in the entry
sequencingPlatformList
List of all validation platforms 
occurring in the entry
validationPlatformList
List of all mapping algorithms 
occurring in the entry
mappingAlgorithmList
List of all fusion detection algorithms occurring in
the entry
fusionDetectionAlgorithmList
List of all sequence repositories used in the 
entry
sequencingRepositoryList
List of all gene fusion 
candidates in the entry
geneFusionList
Figure 2 Graphical representation of the Gene Fusion Markup Language structure. Nine major elements are represented in the figure;
the minor elements and their features can be viewed from the GFML. Mandatory elements are denoted by boxes with solid outlines and optional
elements with open boxes. The plus sign indicates that the parent elements have child elements that are not shown; “1. . .infinite” denotes the
one or many child elements that can occur.
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queries. To avoid redundancy the common elements
such as sample details, experimental design, and protocol
description that have already been discussed and standar-
dized by other efforts were avoided [18,19,32,33,36,40]
and emphasis is placed only on the new data elements
specific to next generation sequencing and gene fusion
analyses. We believe there are much room to improve
upon these vocabularies as the system progresses and
becomes widely adopted by the community.
Discussion and conclusions
Each successful surveying information system that devel-
oped and supported by a community has adopted,
during its evolution, certain standard procedures that
were warranted for data integrity and interoperability.
Although a vast amount of microarray data and protein-
protein interaction data were generated and reported
in the public domain in a non-standard manner, over
time the impaired status of data access and integrated
analyses were exposed. In response to these issues, com-
munities designed and developed appropriate standard-
ization procedures such as MIAME / MAGE-ML [18]
and PSI [19]. A number of gene fusion candidates from
NGS studies have been recently reported without con-
forming to any standardized procedures for describing
and documenting the associated data. Because of this
lack of standardization, there is an enormous risk of
inaccessibility of such valuable information that can con-
sequently impede data integrity and downstream ana-
lyses. Although the NGS studies are new and still
evolving, the rapid generation of information under-
scores the immediate requirement for a standardization
procedure to represent and document the data in a com-
mon format for publication in a journal and deposition
in a database in an exchangeable fashion. We believe
that our proposed prototype standardization tool, Gene
Fusion Markup Language (GFML) helps in resolving
existing inconsistencies in gene fusion data representa-
tion and will facilitate the development of interoperable
data model that can be dynamically queried and inter-
preted across different systems.
Future plans
The model presented here offers the first necessary steps
towards standardization of gene fusion features to share
and exchange in a common standard format among the
research community. The concept of incorporating the
secondary and tertiary features derived from high
throughput data can be extended to NGS-based de novo
sequencing, gene expression, epigenetics, copy number
variation, comparative genomics, metagenomics and
pathogens. Collaboration with other standardization
consortia will be pursued to further develop and extend
the existing standards. As part of the community
standard initiative, we intend to engage the research
community in discussions and look forward to active
participation by others to catalyze future development.
Additional files
Additional file 1: GFML_Schema.XSD – Describes the XML Schema
Definition (XSD) of Gene Fusion Markup Language, can be viewed
in internal explorer or in any XML editor.
Additional file 2: GFML_common.XSD – Describes the common
reusable elements of Gene Fusion Markup Language, can be
viewed in internal explorer or in any XML editor.
Additional file 3: GFML_prototype_instance.XML – Demonstrate
the Gene Fusion Markup Language prototype with illustration, can
be viewed in internal explorer or in any XML editor.
Additional file 4: GFML_prototype.XML – XML document describes
the prototype of the Gene Fusion Markup Language. It would be
good to view in internal explorer or in any XML editor.
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